Filed with ASX · · 40 pages · English
Recce Pharmaceuticals Ltd. has filed a transaction specific prospectus detailing an offer of options to acquire shares. The prospectus outlines several types of options available, including Attaching Options and Piggyback Options, along with their terms and conditions. It also provides important information regarding the offers, including eligibility, purpose, and use of funds. The offers are set to open and close on specified dates, and the prospectus emphasizes that no cooling-off rights apply.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
TRANSACTION SPECIFIC PROSPECTUS Recce Pharmaceuticals Ltd ACN 124 849 065 The Prospectus contains an offer of: (a) 5,000,000 new Attaching Options for nil consideration, each exercisable at $0.60 and expiring on 30 June 2027, on the basis of one Attaching Option for every two Shares issued to...
Recce Pharmaceuticals Ltd. on 6ix
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals